Junne Kamihara, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ribonuclease III | 7 | 2022 | 275 | 1.180 |
Why?
|
DEAD-box RNA Helicases | 7 | 2022 | 375 | 1.110 |
Why?
|
Paraganglioma | 3 | 2022 | 143 | 1.040 |
Why?
|
Retinoblastoma | 2 | 2017 | 318 | 0.970 |
Why?
|
Fumarate Hydratase | 2 | 2021 | 47 | 0.960 |
Why?
|
Germ-Line Mutation | 6 | 2023 | 1786 | 0.850 |
Why?
|
DNA Mismatch Repair | 2 | 2022 | 424 | 0.850 |
Why?
|
Adrenal Gland Neoplasms | 3 | 2022 | 740 | 0.790 |
Why?
|
Indenes | 1 | 2021 | 57 | 0.780 |
Why?
|
Polycythemia | 1 | 2021 | 126 | 0.760 |
Why?
|
Neuroblastoma | 2 | 2017 | 1225 | 0.670 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2022 | 379 | 0.650 |
Why?
|
Central Nervous System Neoplasms | 3 | 2023 | 895 | 0.640 |
Why?
|
Li-Fraumeni Syndrome | 2 | 2017 | 114 | 0.600 |
Why?
|
Pinealoma | 1 | 2017 | 54 | 0.590 |
Why?
|
Ikaros Transcription Factor | 1 | 2018 | 214 | 0.580 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2017 | 97 | 0.580 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1114 | 0.530 |
Why?
|
Human Development | 1 | 2016 | 124 | 0.530 |
Why?
|
Sarcoma | 3 | 2022 | 1895 | 0.510 |
Why?
|
Pulmonary Blastoma | 2 | 2022 | 33 | 0.440 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2018 | 1515 | 0.410 |
Why?
|
Thyroid Neoplasms | 2 | 2022 | 2274 | 0.410 |
Why?
|
Neoplasms | 8 | 2023 | 21596 | 0.400 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2016 | 484 | 0.390 |
Why?
|
Germ Cells | 4 | 2023 | 628 | 0.350 |
Why?
|
Hamartoma Syndrome, Multiple | 2 | 2021 | 111 | 0.320 |
Why?
|
Neoplastic Syndromes, Hereditary | 3 | 2021 | 241 | 0.320 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2017 | 1860 | 0.310 |
Why?
|
Genetic Predisposition to Disease | 9 | 2022 | 17400 | 0.310 |
Why?
|
Pheochromocytoma | 2 | 2022 | 337 | 0.300 |
Why?
|
Syndrome | 3 | 2022 | 3248 | 0.290 |
Why?
|
Attitude to Health | 1 | 2015 | 2051 | 0.270 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2014 | 2948 | 0.230 |
Why?
|
Chondroitinsulfatases | 1 | 2023 | 16 | 0.230 |
Why?
|
Registries | 3 | 2022 | 8077 | 0.230 |
Why?
|
Child | 21 | 2023 | 77478 | 0.230 |
Why?
|
Myofibromatosis | 1 | 2023 | 30 | 0.220 |
Why?
|
Parents | 2 | 2023 | 3387 | 0.220 |
Why?
|
Normetanephrine | 1 | 2021 | 26 | 0.210 |
Why?
|
MutS Homolog 2 Protein | 1 | 2022 | 200 | 0.210 |
Why?
|
Child, Preschool | 11 | 2022 | 40955 | 0.200 |
Why?
|
Chromogranins | 1 | 2021 | 163 | 0.190 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2022 | 224 | 0.180 |
Why?
|
Genetic Testing | 3 | 2022 | 3439 | 0.180 |
Why?
|
DNA Repair Enzymes | 1 | 2021 | 349 | 0.170 |
Why?
|
Adrenal Glands | 1 | 2021 | 547 | 0.170 |
Why?
|
Rare Diseases | 1 | 2023 | 554 | 0.160 |
Why?
|
Multiple Endocrine Neoplasia | 1 | 2017 | 25 | 0.150 |
Why?
|
Kidney Neoplasms | 3 | 2021 | 4229 | 0.150 |
Why?
|
Thyroid Diseases | 1 | 2021 | 378 | 0.150 |
Why?
|
Basal Cell Nevus Syndrome | 1 | 2017 | 40 | 0.150 |
Why?
|
Leiomyomatosis | 1 | 2017 | 70 | 0.150 |
Why?
|
Jaw Neoplasms | 1 | 2017 | 70 | 0.150 |
Why?
|
Adolescent | 11 | 2022 | 85649 | 0.140 |
Why?
|
BRCA2 Protein | 2 | 2023 | 790 | 0.140 |
Why?
|
Humans | 37 | 2023 | 742088 | 0.140 |
Why?
|
von Hippel-Lindau Disease | 1 | 2017 | 152 | 0.140 |
Why?
|
Hyperparathyroidism | 1 | 2017 | 339 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2017 | 220 | 0.130 |
Why?
|
Fibroma | 1 | 2017 | 212 | 0.130 |
Why?
|
PTEN Phosphohydrolase | 2 | 2021 | 1144 | 0.130 |
Why?
|
Rhabdoid Tumor | 1 | 2017 | 212 | 0.130 |
Why?
|
Thyroid Nodule | 1 | 2022 | 750 | 0.120 |
Why?
|
Genetic Variation | 2 | 2021 | 6540 | 0.120 |
Why?
|
Early Detection of Cancer | 4 | 2021 | 3070 | 0.120 |
Why?
|
Wilms Tumor | 1 | 2016 | 368 | 0.120 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2017 | 1659 | 0.110 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2016 | 600 | 0.110 |
Why?
|
Infant | 5 | 2022 | 35070 | 0.100 |
Why?
|
DNA Helicases | 1 | 2017 | 861 | 0.100 |
Why?
|
Female | 14 | 2023 | 379592 | 0.100 |
Why?
|
Neuromyelitis Optica | 1 | 2014 | 253 | 0.090 |
Why?
|
Genetic Counseling | 1 | 2014 | 600 | 0.090 |
Why?
|
Genotype | 3 | 2022 | 12946 | 0.090 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2022 | 3585 | 0.090 |
Why?
|
Proto-Oncogene Proteins | 2 | 2017 | 4553 | 0.080 |
Why?
|
Male | 11 | 2023 | 349538 | 0.080 |
Why?
|
Genetic Association Studies | 1 | 2018 | 2699 | 0.080 |
Why?
|
Lung Neoplasms | 2 | 2022 | 13019 | 0.080 |
Why?
|
Brain Neoplasms | 2 | 2021 | 8829 | 0.080 |
Why?
|
Interviews as Topic | 1 | 2015 | 2536 | 0.080 |
Why?
|
Uterine Neoplasms | 1 | 2017 | 1513 | 0.080 |
Why?
|
Homeodomain Proteins | 1 | 2017 | 2417 | 0.080 |
Why?
|
Social Class | 1 | 2016 | 1995 | 0.080 |
Why?
|
Transcription Factors | 2 | 2017 | 12164 | 0.070 |
Why?
|
Glioma | 1 | 2022 | 3388 | 0.070 |
Why?
|
Adult | 8 | 2023 | 213712 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 1 | 2017 | 2842 | 0.070 |
Why?
|
Residence Characteristics | 1 | 2016 | 2049 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2023 | 4823 | 0.070 |
Why?
|
Adenoma | 1 | 2017 | 2168 | 0.070 |
Why?
|
Bone Marrow Transplantation | 1 | 2014 | 2763 | 0.070 |
Why?
|
Poverty | 1 | 2016 | 2646 | 0.060 |
Why?
|
Infant, Newborn | 3 | 2023 | 25575 | 0.060 |
Why?
|
Developing Countries | 1 | 2016 | 2789 | 0.060 |
Why?
|
Phenotype | 1 | 2021 | 16331 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 3 | 2021 | 35342 | 0.060 |
Why?
|
Amino Acid Transport System y+L | 1 | 2023 | 17 | 0.060 |
Why?
|
Prognosis | 3 | 2022 | 29010 | 0.060 |
Why?
|
Mutation | 4 | 2022 | 29717 | 0.060 |
Why?
|
Nuclear Proteins | 1 | 2017 | 5851 | 0.050 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2023 | 188 | 0.050 |
Why?
|
Antiporters | 1 | 2023 | 277 | 0.050 |
Why?
|
3-Iodobenzylguanidine | 1 | 2022 | 115 | 0.050 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2023 | 440 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6754 | 0.050 |
Why?
|
Loss of Heterozygosity | 1 | 2023 | 678 | 0.050 |
Why?
|
Receptors, Growth Factor | 1 | 2001 | 334 | 0.040 |
Why?
|
Risk Factors | 5 | 2021 | 72145 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2022 | 77098 | 0.040 |
Why?
|
Neonatal Screening | 1 | 2023 | 591 | 0.040 |
Why?
|
Signal Transduction | 1 | 2021 | 23387 | 0.040 |
Why?
|
Incidence | 1 | 2016 | 20928 | 0.040 |
Why?
|
Multiple Endocrine Neoplasia Type 2b | 1 | 2017 | 10 | 0.040 |
Why?
|
Radionuclide Imaging | 1 | 2022 | 2027 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2017 | 5662 | 0.040 |
Why?
|
BRCA1 Protein | 1 | 2023 | 1145 | 0.040 |
Why?
|
Prospective Studies | 4 | 2023 | 53187 | 0.040 |
Why?
|
Genomics | 2 | 2023 | 5692 | 0.040 |
Why?
|
Penetrance | 1 | 2018 | 380 | 0.030 |
Why?
|
Doxorubicin | 1 | 2022 | 2215 | 0.030 |
Why?
|
Inheritance Patterns | 1 | 2018 | 340 | 0.030 |
Why?
|
Young Adult | 4 | 2023 | 56350 | 0.030 |
Why?
|
Mass Screening | 2 | 2022 | 5238 | 0.030 |
Why?
|
Fanconi Anemia | 1 | 2016 | 319 | 0.030 |
Why?
|
Plasmapheresis | 1 | 2014 | 212 | 0.030 |
Why?
|
Protein Structure, Tertiary | 1 | 2001 | 3847 | 0.030 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2022 | 2013 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2001 | 1740 | 0.030 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2017 | 628 | 0.030 |
Why?
|
Transfection | 1 | 2001 | 5892 | 0.030 |
Why?
|
Prevalence | 2 | 2021 | 15194 | 0.030 |
Why?
|
Collagen | 1 | 2001 | 2684 | 0.030 |
Why?
|
DNA Damage | 1 | 2022 | 2423 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2022 | 2658 | 0.030 |
Why?
|
Optic Nerve | 1 | 2014 | 548 | 0.020 |
Why?
|
Middle Aged | 2 | 2023 | 213127 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2022 | 2723 | 0.020 |
Why?
|
Prenatal Diagnosis | 1 | 2018 | 1232 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2001 | 2633 | 0.020 |
Why?
|
Population Surveillance | 1 | 2021 | 2616 | 0.020 |
Why?
|
Cell Movement | 1 | 2001 | 5212 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2001 | 4455 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2001 | 5095 | 0.020 |
Why?
|
Ultrasonography | 1 | 2021 | 5978 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2001 | 3843 | 0.020 |
Why?
|
Disease Management | 1 | 2018 | 2450 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12773 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2022 | 6259 | 0.020 |
Why?
|
Spinal Cord | 1 | 2014 | 1807 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2017 | 3020 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2017 | 3691 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8621 | 0.020 |
Why?
|
Pilot Projects | 1 | 2017 | 8297 | 0.020 |
Why?
|
Disease Progression | 1 | 2021 | 13256 | 0.020 |
Why?
|
United States | 2 | 2021 | 69693 | 0.010 |
Why?
|
Collagen Type XVIII | 1 | 2001 | 56 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 24913 | 0.010 |
Why?
|
Endostatins | 1 | 2001 | 174 | 0.010 |
Why?
|
rac GTP-Binding Proteins | 1 | 2001 | 163 | 0.010 |
Why?
|
Cytotoxins | 1 | 2001 | 153 | 0.010 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2001 | 194 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39004 | 0.010 |
Why?
|
rho GTP-Binding Proteins | 1 | 2001 | 293 | 0.010 |
Why?
|
Dimerization | 1 | 2001 | 893 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12958 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 20086 | 0.010 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2014 | 3497 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 2001 | 1676 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 40450 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2023 | 57683 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2001 | 552 | 0.010 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2001 | 664 | 0.010 |
Why?
|
Algorithms | 1 | 2018 | 13853 | 0.010 |
Why?
|
Morphogenesis | 1 | 2001 | 752 | 0.010 |
Why?
|
Adenoviridae | 1 | 2001 | 1096 | 0.010 |
Why?
|
Risk Assessment | 1 | 2018 | 23320 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2001 | 1284 | 0.010 |
Why?
|
Bacterial Toxins | 1 | 2001 | 933 | 0.010 |
Why?
|
Cell Division | 1 | 2001 | 4564 | 0.010 |
Why?
|
Blotting, Western | 1 | 2001 | 5180 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2001 | 6313 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2001 | 3770 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2001 | 2038 | 0.010 |
Why?
|
Aged | 1 | 2023 | 162944 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2001 | 13814 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2001 | 18112 | 0.000 |
Why?
|
Cells, Cultured | 1 | 2001 | 19223 | 0.000 |
Why?
|
Mice | 2 | 2001 | 81045 | 0.000 |
Why?
|
Animals | 2 | 2001 | 168561 | 0.000 |
Why?
|